United States News All stories

MSCI (NYSE:MSCI) reported third-quarter 2026 operating revenue of $892 million, representing a 12.4% increase from the corresponding period in 2025.

General Motors (NYSE:GM) reported third-quarter 2026 revenue of $50 billion, while net income attributable to shareholders increased to $3.335 billion.

Dime Commercial Bancshares (NYSE:DCOM) reported third-quarter 2026 net income available to common stockholders of $39.7 million, with diluted earnings increasing 53% to $0.90 per share.

Hasbro (NASDAQ:HAS) reported third-quarter 2026 revenue growth of 15% to approximately $1.60 billion, driven by higher sales across gaming, consumer products and entertainment.

Commerce Bancshares (NASDAQ:CBSH) reported third-quarter 2026 net income of $155 million, up 9.5% year over year, with diluted earnings reaching $1.08 per share.

Northrop Grumman (NYSE:NOC) reported third-quarter 2026 earnings of $7.89 per share, beating analysts' $7.18 consensus estimate by $0.71.

Synchrony Financial (NYSE:SYF) reported third-quarter 2026 diluted earnings of $2.68 per share, exceeding the cited $2.48 analyst estimate despite declining profits.

Peoples Bancorp (NASDAQ:PEBO) reported third-quarter 2026 net income of $32.6 million, with diluted earnings of $0.91 per share.

DEFSEC Technologies (NASDAQ:DFSC) reported preliminary cash and cash equivalents of approximately $7.7 million at September 30, 2026, more than doubling its June balance.

Mercantile Bank Corporation (NASDAQ:MBWM) reported third-quarter 2026 net income of $24.1 million, slightly above the $23.8 million earned a year earlier.

Alvotech (NASDAQ:ALVO) received FDA approval for a manufacturing process that more than doubles SIMLANDI drug substance output per batch at its Iceland facility.

Fortuna Mining (NYSE:FSM) reported gold mineralization below Lindero's current reserve pit design, including a 350-meter intersection averaging 0.96 grams per tonne.

Mercantile Bank Corporation (NASDAQ:MBWM) declared a quarterly cash dividend of $0.40 per common share, payable December 16, 2026, to eligible shareholders.

Cognizant (NASDAQ:CTSH) announced a five-year agreement with payment technology company Ingenico to modernize its global technology infrastructure, applications and data operations.

Brent crude futures rose 0.47% to $110.07 per barrel on October 20, 2026, as Middle Eastern security risks supported oil prices.

BW LPG (NYSE:BWLP) announced an agreement to sell its 2008-built BW Loyalty vessel, expecting an approximately $52 million disposal gain.

Anteris Technologies Global (NASDAQ:AVR) received full German regulatory clearance to recruit patients for its global PARADIGM trial evaluating the DurAVR heart valve.

Grupo Aeroportuario del Pacífico (NYSE:PAC) reported third-quarter 2026 net income of Ps. 2,914.1 million, an 8.1% increase from a year earlier.

Oracle (NYSE:ORCL) announced a non-binding collaboration with AstraZeneca (NASDAQ:AZN) to explore artificial intelligence and real-world data applications in clinical research.

Oculis (NASDAQ:OCS) will present new Phase 2 ACUITY biomarker analyses of its investigational Privosegtor treatment on October 22, 2026, in Toronto.

Kenvue (NYSE:KVUE) lost its bid to reconsider a federal appeals ruling reviving approximately 500 lawsuits alleging prenatal Tylenol exposure caused autism or ADHD.

Apple (NASDAQ:AAPL) faces potential additional patent damages after Taction Technology requested interest and compensation beyond a September jury verdict exceeding $5.7 billion.

United Therapeutics (NASDAQ:UTHR) received FDA clearance to proceed with a Phase 2 trial of treprostinil SMI for pulmonary hypertension associated with COPD.

Cullinan Therapeutics (NASDAQ:CGEM) and Taiho Oncology reported a 30.2% intracranial response rate for zipalertinib in 43 evaluable lung cancer patients with brain metastases.